Sunday said Pennsylvanians taking these drugs should ensure they are getting them from a licensed pharmacy. As demand for GLP-1 drugs rises, so does the counterfeit market for diabetes control and weight-loss drugs.
“These counterfeit products flooding the market can cause harm, and I strongly advise anyone shopping for GLP-1 drugs to use extreme caution,” Attorney General Sunday said. “I continue to urge the FDA to use its investigative, inspection, and enforcement powers to protect consumers.”
Sunday was involved in a multi-state coalition letter sent to the Food and Drug Administration, advising them to crack down on these counterfeit drugs that often come from foreign countries.
As summer approaches, more people are looking to embark on a weight loss journey. Those looking to take GLP-1 drugs such as Mounjaro, Zepbound, Ozempic, and Wegovy should take the proper steps to ensure they are getting medication from a proper source, Sunday says.
Consumers are encouraged to report suspicious products to the FDA and the Pennsylvania Office of the Attorney General.
An oversized load truck damaged a bridge on Kishwaukee Street Thursday, April 16, reducing the…
SHELBYVILLE, Ind. (WOWO) — A female is dead after a shooting in Shelbyville, and two…
A bill requiring public health clinics to report immigrant patients without legal status is headed…
Despite opposition from members of the public and a bipartisan group of lawmakers, moves to…
The Village of Roscoe is continuing cleanup from last weekend's storms and has implemented temporary…
As part of the Sonos Earth Day Sale event that ends on April 24, Sonos…
This website uses cookies.